However, the effect of BMI on CRC risk in pathogenic PMS2 and MSH6 carriers was not studied, revealing a potential limitation since adiposity could have been a decisive modifier considering the low penetrance of these two genes [50]. This evidence concerns the gene PMS2 and colorectal carcinoma.